<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="issn">1043-3155</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol Briefs</journal-id>
<journal-id journal-id-type="pmc">pedneurbriefs</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr Neurol Briefs</journal-id>
<journal-title-group>
<journal-title>Pediatric Neurology Briefs</journal-title>
<abbrev-journal-title>Pediatr Neurol Briefs</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1043-3155</issn>
<issn pub-type="epub">2166-6482</issn>
<issn-l>1043-3155</issn-l>
<publisher>
<publisher-name>Pediatric Neurology Briefs Publishers</publisher-name>
<publisher-loc>Chicago, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNB-2015-29-6-5</article-id>
<article-id pub-id-type="doi">10.15844/pedneurbriefs-29-6-5</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Demyelinating Disorders</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Neurology</subject>
<subject>Pediatrics</subject>
<subject>Nervous System Diseases</subject>
<subject>Child Development</subject>
<subject>Brain Diseases</subject>
<subject>Neurosurgery</subject>
<subject>Child</subject>
<subject>Infant</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Prognostic Factors of MS Conversion in Optic Neuritis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Fajardo</surname>
<given-names>Marytery</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Rubin</surname>
<given-names>Jennifer P.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Division of Neurology, Ann &#x0026; Robert H. Lurie Children&#x0027;s Hospital of Chicago, Chicago, IL</aff>
<aff id="AF0002">
<label>2</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Correspondence: Dr Jennifer P. Rubin, Email: <email xlink:href="jerubin@luriechildrens.org">jerubin@luriechildrens.org</email>
</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="print">
<month>06</month>
<year>2015</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>30</day>
<month>06</month>
<year>2015</year>
</pub-date>
<volume>29</volume>
<issue>6</issue>
<fpage>46</fpage>
<lpage>46</lpage>
<history>
<date date-type="received">
<day>22</day>
<month>06</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>06</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright: &#x00A9; 2015 The Author(s)</copyright-statement>
<copyright-year>2015</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under the <uri xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="R1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.1016/j.jpeds.2015.01.039" vol="77" page="1076">
<article-title>Oligoclonal bands predict multiple sclerosis in children with optic neuritis</article-title>
</related-article>
<abstract abstract-type="web-summary" specific-use="electronic-only">
<p>Investigators from Children&#x0027;s Hospital Aschaffenburg, Germany; University of Manchester, Manchester, United Kingdom; University Children&#x0027;s Hospital T&#x00FC;bingen, T&#x00FC;bingen, Germany; and other international centers studied prognostic factors in optic neuritis.</p>
</abstract>
<kwd-group>
<kwd>Optic Neuritis</kwd>
<kwd>Multiple Sclerosis</kwd>
<kwd>Oligoclonal Bands</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Investigators from Children&#x0027;s Hospital Aschaffenburg, Germany; University of Manchester, Manchester, United Kingdom; University Children&#x0027;s Hospital T&#x00FC;bingen, T&#x00FC;bingen, Germany; and other international centers studied prognostic factors in optic neuritis. They retrospectively reviewed 357 children treated at 27 different hospitals presenting with isolated optic neuritis and with a median follow up of 4 years to evaluate for factors predicting eventual conversion to multiple sclerosis. Factors they reviewed included baseline abnormal MRI, presence of cerebrospinal fluid immunoglobulin G oligoclonal bands, sex, and laterality of optic neuritis (unilateral versus bilateral). They used Multiple Cox proportional-hazards regressions to identify abnormal MRI and CSF oligoclonal bands as independent predictors of conversion to multiple sclerosis, (cMRI: hazard ratio [HR]= 5.94, 95% confidence interval 3.39-10.39, p &#x003C; 0.001; OCB: HR = 3.69, 95% CI = 2.32-5.86, p &#x003C; 0.001), with an even higher risk when both factors were present (HR = 26.84, 95% CI = 12.26-58.74, p &#x003C; 0.001). They also identified age as an independent risk factor, with a hazard ratio of 1.08 per year of age, 95% CI = 1.02-1.13, p = 0.003. They found that sex and whether the optic neuritis was unilateral or bilateral at presentation did not have any prognostic value. The authors also found that only 9 of 115 patients without oligoclonal bands and with a negative MRI developed MS within 4 years. Moreover, none of the 5 children with a final diagnosis of neuromyelitis optica had CSF oligoclonal bands during initial presentation. [<xref ref-type="bibr" rid="CIT0001">1</xref>]</p>
<p>COMMENTARY. Although patients often improve significantly if not completely, optic neuritis in children often poses a prognostication challenge for the child neurologist. The authors of this study found a multiple sclerosis (MS) conversion rate of 40.6% after median of 4 years follow up, which is greater than prior studies have indicated, including 36% identified after two year follow up in a 2006 study [<xref ref-type="bibr" rid="CIT0001">1</xref>, <xref ref-type="bibr" rid="CIT0002">2</xref>]. This finding may be related to more sensitive diagnostic criteria for MS than in past studies or a change in the natural history of childhood optic neuritis and MS [<xref ref-type="bibr" rid="CIT0001">1</xref>, <xref ref-type="bibr" rid="CIT0003">3</xref>]. Regardless, this indicates that often, optic neuritis is not a benign self-limited event, and children who present with unilateral or bilateral optic neuritis may develop MS in the future.</p>
<p>Various studies have shown a benefit to prophylactic immunotherapy for adults with a clinically isolated syndrome [<xref ref-type="bibr" rid="CIT0004">4</xref>], but similar data is not available for children [<xref ref-type="bibr" rid="CIT0005">5</xref>]. It is then helpful for the clinician to have reliable prognostic evidence available to aid in decision making about when to initiate prophylactic treatment for MS. This study suggests that a thorough evaluation that includes CSF analysis for the presence of oligoclonal bands may be indicated in the initial evaluation of a pediatric patient presenting with optic neuritis, especially if MRI is not diagnostic of MS. Furthermore, this study reiterates the importance of following children with optic neuritis over time, with serial neuroimaging.</p>
</body>
<back>
<sec>
<title>Disclosures</title>
<p>The authors have declared that no competing interests exist.</p>
</sec>
<ref-list>
<ref id="CIT0001">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heussinger</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kontopantelis</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gburek-Augustat</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jenke</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vollrath</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Korinthenberg</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>
<source>Oligoclonal bands predict multiple sclerosis in children with optic neuritis. Ann Neurol</source>
<year>2015</year>
<volume>77</volume>
<issue>6</issue>
<fpage>1076</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="doi">10.1002/ana.24409</pub-id>
<pub-id pub-id-type="pmid">25820181</pub-id>
</element-citation>
</ref>
<ref id="CIT0002">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilejto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shroff</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Buncic</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Goia</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Banwell</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>The clinical features, MRI findings, and outcome of optic neuritis in children</article-title>
<source>Neurology</source>
<year>2006</year>
<volume>67</volume>
<issue>2</issue>
<fpage>258</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="doi">10.1212/01.wnl.0000224757.69746.fb</pub-id>
<pub-id pub-id-type="pmid">16864818</pub-id>
</element-citation>
</ref>
<ref id="CIT0003">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rubin</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Kuntz</surname>
<given-names>NL</given-names>
</name>
</person-group>
<article-title>Diagnostic criteria for pediatric multiple sclerosis</article-title>
<source>Curr Neurol Neurosci Rep</source>
<year>2013</year>
<volume>13</volume>
<issue>6</issue>
<fpage>354</fpage>
<pub-id pub-id-type="doi">10.1007/s11910-013-0354-3</pub-id>
<pub-id pub-id-type="pmid">23591756</pub-id>
</element-citation>
</ref>
<ref id="CIT0004">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clerico</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Faggiano</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Palace</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rice</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Tintore</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Durelli</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis</article-title>
<source>Cochrane Database Syst Rev</source>
<volume>2008</volume>
<issue>2</issue>
<fpage>Cd005278</fpage>
<pub-id pub-id-type="doi">10.1002/14651858.CD005278.pub3</pub-id>
<pub-id pub-id-type="pmid">18425915</pub-id>
</element-citation>
</ref>
<ref id="CIT0005">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jayakody</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bonthius</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Longmuir</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Joshi</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Pediatric optic neuritis: does a prolonged course of steroids reduce relapses? A preliminary study</article-title>
<source>Pediatr Neurol</source>
<year>2014</year>
<volume>51</volume>
<issue>5</issue>
<fpage>721</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2014.07.020</pub-id>
<pub-id pub-id-type="pmid">25152962</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
